ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

JSPR Jasper Therapeutics Inc

20.40
-0.78 (-3.68%)
After Hours
Last Updated: 17:34:19
Delayed by 15 minutes

Period:

Draw Mode:

Volume 52,241
Bid Price 20.51
Ask Price 22.00
News -
Day High 21.5599

Low
4.00

52 Week Range

High
31.01

Day Low 20.15
Company Name Stock Ticker Symbol Market Type
Jasper Therapeutics Inc JSPR NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.78 -3.68% 20.40 17:34:19
Open Price Low Price High Price Close Price Prev Close
21.18 20.15 21.5599 20.40 21.18
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
1,692 52,241 $ 20.97 $ 1,095,717 - 4.00 - 31.01
Last Trade Time Type Quantity Stock Price Currency
17:16:27 50 $ 20.50 USD

Jasper Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
307M 15.06M - 0 -64.47M -4.28 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Jasper Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No JSPR Message Board. Create One! See More Posts on JSPR Message Board See More Message Board Posts

Historical JSPR Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week23.2124.6120.1521.9169,184-2.81-12.11%
1 Month30.7531.0120.1525.7277,457-10.35-33.66%
3 Months12.1331.0111.2522.88117,7198.2768.18%
6 Months7.6031.014.008.36360,24212.80168.42%
1 Year11.9031.014.0010.01346,6448.5071.43%
3 Years140.60188.803.86256.49829,635-120.20-85.49%
5 Years140.60188.803.86256.49829,635-120.20-85.49%

Jasper Therapeutics Description

Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.

Your Recent History

Delayed Upgrade Clock